Gerald Brooks

740 total citations
25 papers, 464 citations indexed

About

Gerald Brooks is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Gerald Brooks has authored 25 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Organic Chemistry, 14 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Gerald Brooks's work include Synthesis of β-Lactam Compounds (6 papers), Microbial Natural Products and Biosynthesis (4 papers) and Synthetic Organic Chemistry Methods (4 papers). Gerald Brooks is often cited by papers focused on Synthesis of β-Lactam Compounds (6 papers), Microbial Natural Products and Biosynthesis (4 papers) and Synthetic Organic Chemistry Methods (4 papers). Gerald Brooks collaborates with scholars based in United States, United Kingdom and Spain. Gerald Brooks's co-authors include Robert Southgate, Eric Hunt, Peter Edwards, P. H. BENTLEY, Kenneth Coleman, Martin Goss, Ian R. Hart, Thomas P. Dooley, R. Wilson and Aileen E Allsop and has published in prestigious journals such as Tetrahedron, Tetrahedron Letters and Bioorganic & Medicinal Chemistry.

In The Last Decade

Gerald Brooks

23 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald Brooks United States 13 286 201 73 67 47 25 464
HARUO YAMAMOTO Japan 14 286 1.0× 192 1.0× 213 2.9× 81 1.2× 30 0.6× 30 535
J. I. CIALDELLA United States 13 264 0.9× 156 0.8× 169 2.3× 38 0.6× 58 1.2× 31 484
L. J. Haňka United States 13 453 1.6× 243 1.2× 154 2.1× 14 0.2× 84 1.8× 31 675
A Matsumae Japan 9 180 0.6× 111 0.6× 115 1.6× 17 0.3× 19 0.4× 30 381
LaVerne D. Boeck United States 13 414 1.4× 251 1.2× 323 4.4× 53 0.8× 24 0.5× 16 689
Mostafa M. Hamed Germany 12 280 1.0× 352 1.8× 95 1.3× 45 0.7× 39 0.8× 44 579
H Shimada Japan 14 267 0.9× 99 0.5× 92 1.3× 27 0.4× 20 0.4× 34 506
Yutaka Tatano Japan 14 188 0.7× 73 0.4× 50 0.7× 16 0.2× 41 0.9× 31 482
Masami Hatori Germany 14 311 1.1× 225 1.1× 274 3.8× 9 0.1× 68 1.4× 23 607
Jeremiah S. Helm United States 8 309 1.1× 177 0.9× 106 1.5× 64 1.0× 14 0.3× 9 453

Countries citing papers authored by Gerald Brooks

Since Specialization
Citations

This map shows the geographic impact of Gerald Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Brooks more than expected).

Fields of papers citing papers by Gerald Brooks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Brooks. The network helps show where Gerald Brooks may publish in the future.

Co-authorship network of co-authors of Gerald Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Brooks. A scholar is included among the top collaborators of Gerald Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Brooks. Gerald Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miles, Timothy J., Alan J. Hennessy, B.D. Bax, et al.. (2016). Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases. Bioorganic & Medicinal Chemistry Letters. 26(10). 2464–2469. 33 indexed citations
2.
Miles, Timothy J., Gerald Brooks, Pamela Brown, et al.. (2011). Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases. Bioorganic & Medicinal Chemistry Letters. 21(24). 7483–7488. 33 indexed citations
3.
Allsop, Aileen E, Gerald Brooks, Peter Edwards, Arun C. Kaura, & Robert Southgate. (1996). Inhibitors of Bacterial Signal Peptidase: A Series of 6-(Substituted oxyethyl)penems.. The Journal of Antibiotics. 49(9). 921–928. 35 indexed citations
4.
Allsop, Aileen E, Gerald Brooks, Gordon Bruton, et al.. (1995). Penem inhibitors of bacterial signal peptidase. Bioorganic & Medicinal Chemistry Letters. 5(5). 443–448. 43 indexed citations
5.
Brooks, Gerald, et al.. (1995). Synthesis of derivatives of muramic acid and C-1 homologated α-D-glucose as potential inhibitors of bacterial transglycosylase. Tetrahedron. 51(29). 7999–8014. 26 indexed citations
6.
Scholz, D., et al.. (1994). Fruit acid extracts, a fresh approach to skin renewal. International Journal of Cosmetic Science. 16(6). 265–272. 9 indexed citations
7.
Brooks, Gerald, et al.. (1991). 6-(Substituted methylene)penems, potent broad spectrum inhibitors of bacterial .BETA.-lactamase. V. Chiral 1,2,3-triazolyl derivatives.. The Journal of Antibiotics. 44(9). 969–978. 61 indexed citations
8.
Brooks, Gerald, R. Wilson, Thomas P. Dooley, Martin Goss, & Ian R. Hart. (1991). Protein kinase C down-regulation, and not transient activation, correlates with melanocyte growth.. PubMed. 51(12). 3281–8. 58 indexed citations
9.
Brooks, Gerald, et al.. (1988). Synthesis and .BETA.-lactamase inhibitory activity of 9-(2-amidoethenylthio)-9-deoxy derivatives of clavulanic acid.. The Journal of Antibiotics. 41(7). 892–898. 13 indexed citations
10.
Brooks, Gerald, et al.. (1984). Nuclear modification of clavulanic acid. Preparation of optically active 1-oxaceph-3-ems. Journal of the Chemical Society Perkin Transactions 1. 1599–1599. 2 indexed citations
11.
Brooks, Gerald & Eric Hunt. (1983). Oxidative decarboxylation of clavulanic acid and its 9-methyl ether. Journal of the Chemical Society Perkin Transactions 1. 2513–2513. 3 indexed citations
12.
Brooks, Gerald & Eric Hunt. (1983). Nuclear modification of clavulanic acid. The preparation of two 4,7-fused β-lactam systems. Journal of the Chemical Society Perkin Transactions 1. 115–120. 3 indexed citations
13.
Brooks, Gerald, T. Trefor Howarth, & Eric Hunt. (1981). Synthesis of ethyl 3-methyl-7-oxo-4-oxo-4-oxa-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate and the reaction of 4-acetoxyazetidin-2-one with ethyl α-diazoacetoacetate. Journal of the Chemical Society Chemical Communications. 642–643. 12 indexed citations
14.
15.
BENTLEY, P. H., Gerald Brooks, Martin L. Gilpin, & Eric Hunt. (1979). A new total synthesis of (±)-clavulanic acid. Tetrahedron Letters. 20(21). 1889–1890. 10 indexed citations
16.
BENTLEY, P. H., et al.. (1977). Total synthesis of (±)-clavulanic acid. Journal of the Chemical Society Chemical Communications. 748–749. 13 indexed citations
17.
Hunt, Eric, P. H. BENTLEY, Gerald Brooks, & Martin L. Gilpin. (1977). Total synthesis of β-lactamase inhibitors related to clavulanic acid. Journal of the Chemical Society Chemical Communications. 0(24). 906–907. 8 indexed citations
18.
BENTLEY, P. H. & Gerald Brooks. (1976). Semi-synthetic penicillins and cephalosporins incorporating a hydroxyamino group. Tetrahedron Letters. 17(41). 3735–3738. 2 indexed citations
19.
BENTLEY, P. H., et al.. (1976). Phthalidyl esters of cerhalosporins. Tetrahedron Letters. 17(41). 3739–3742. 12 indexed citations
20.
Brooks, Gerald, et al.. (1973). Keten. Part XII. Addition reactions of ketens with azo-compounds. Journal of the Chemical Society Perkin Transactions 1. 1297–1297.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026